0.9793
price up icon1.25%   0.0121
after-market After Hours: 1.00 0.0207 +2.11%
loading
Adicet Bio Inc stock is traded at $0.9793, with a volume of 3.05M. It is up +1.25% in the last 24 hours and up +20.87% over the past month. Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
See More
Previous Close:
$0.9672
Open:
$1.04
24h Volume:
3.05M
Relative Volume:
3.02
Market Cap:
$81.53M
Revenue:
$24.99M
Net Income/Loss:
$-118.64M
P/E Ratio:
-0.7476
EPS:
-1.31
Net Cash Flow:
$-100.25M
1W Performance:
-2.07%
1M Performance:
+20.87%
6M Performance:
+82.36%
1Y Performance:
-29.55%
1-Day Range:
Value
$0.9175
$1.0899
1-Week Range:
Value
$0.7896
$1.0899
52-Week Range:
Value
$0.4471
$1.54

Adicet Bio Inc Stock (ACET) Company Profile

Name
Name
Adicet Bio Inc
Name
Phone
617-482-2333
Name
Address
131 DARTMOUTH STREET, BOSTON
Name
Employee
152
Name
Twitter
Name
Next Earnings Date
2024-12-06
Name
Latest SEC Filings
Name
ACET's Discussions on Twitter

Compare ACET with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ACET
Adicet Bio Inc
0.9793 148.23M 24.99M -118.64M -100.25M -1.31
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Adicet Bio Inc Stock (ACET) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-30-24 Resumed Guggenheim Buy
Sep-11-24 Downgrade H.C. Wainwright Buy → Neutral
Jun-27-23 Downgrade Guggenheim Buy → Neutral
Jun-27-23 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-01-23 Downgrade JP Morgan Overweight → Neutral
Sep-21-22 Initiated JP Morgan Overweight
Mar-31-22 Initiated SMBC Nikko Outperform
Mar-08-22 Initiated Truist Buy
Mar-04-22 Initiated Jefferies Buy
May-18-21 Initiated BTIG Research Buy
Apr-23-21 Initiated H.C. Wainwright Buy
Apr-14-21 Initiated Canaccord Genuity Buy
Apr-08-21 Initiated Guggenheim Buy
Nov-04-20 Initiated B. Riley Securities Buy
Oct-27-20 Initiated JMP Securities Mkt Outperform
Oct-16-20 Initiated Wedbush Outperform
View All

Adicet Bio Inc Stock (ACET) Latest News

pulisher
08:23 AM

How sentiment analysis helps forecast Adicet Bio Inc.Quarterly Trade Report & Community Verified Swing Trade Signals - newser.com

08:23 AM
pulisher
08:23 AM

Why Adicet Bio Inc. (1IJA) stock could rally strongly2025 Market Outlook & AI Driven Stock Movement Reports - newser.com

08:23 AM
pulisher
08:01 AM

How strong is Adicet Bio Inc. stock revenue growth2025 Earnings Impact & Free Technical Pattern Based Buy Signals - newser.com

08:01 AM
pulisher
Oct 10, 2025

Orbimed advisors buys Adicet Bio (ACET) shares worth $5 million - Investing.com India

Oct 10, 2025
pulisher
Oct 10, 2025

Orbimed advisors buys Adicet Bio (ACET) shares worth $5 million By Investing.com - Investing.com UK

Oct 10, 2025
pulisher
Oct 10, 2025

What moving averages say about Adicet Bio Inc.2025 Price Targets & Entry Point Confirmation Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Multi factor analysis applied to Adicet Bio Inc.July 2025 Institutional & Real-Time Stock Movement Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Adicet Bio’s SWOT analysis: cell therapy stock faces pivotal moment By Investing.com - Investing.com Australia

Oct 09, 2025
pulisher
Oct 09, 2025

What RSI levels show for Adicet Bio Inc. (1IJA) stockJuly 2025 Reactions & High Conviction Investment Ideas - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Guggenheim Maintains Adicet Bio (ACET) Buy Recommendation - Nasdaq

Oct 08, 2025
pulisher
Oct 08, 2025

Adicet Bio’s SWOT analysis: cell therapy stock faces pivotal moment - Investing.com India

Oct 08, 2025
pulisher
Oct 08, 2025

Adicet Bio (NASDAQ:ACET) Earns Sell (E+) Rating from Weiss Ratings - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Adicet Bio Inc Stock Analysis and ForecastBreakout Stock Watch & Grow Steadily With Our Wealth Roadmap - earlytimes.in

Oct 08, 2025
pulisher
Oct 08, 2025

Adicet Bio stock holds steady as Citizens reiterates Market Perform - Investing.com

Oct 08, 2025
pulisher
Oct 08, 2025

Adicet Bio reports positive results from ADI-001 autoimmune trial By Investing.com - Investing.com Canada

Oct 08, 2025
pulisher
Oct 07, 2025

Adicet Bio Receives Nasdaq Extension for Compliance - TipRanks

Oct 07, 2025
pulisher
Oct 07, 2025

Guggenheim raises Adicet Bio stock price target on positive lupus data - Investing.com

Oct 07, 2025
pulisher
Oct 07, 2025

Adicet Bio Announces $80 Million Offering - citybiz

Oct 07, 2025
pulisher
Oct 07, 2025

Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2 - Benzinga

Oct 07, 2025
pulisher
Oct 07, 2025

Are Medical Stocks Lagging Exact Sciences (EXAS) This Year? - sharewise.com

Oct 07, 2025
pulisher
Oct 07, 2025

Adicet Bio prices $80 million stock offering at $1 per share - Investing.com Nigeria

Oct 07, 2025
pulisher
Oct 07, 2025

Adicet Bio reports positive results from ADI-001 autoimmune trial - Investing.com

Oct 07, 2025
pulisher
Oct 07, 2025

Adicet Bio Announces Major Stock Offering Agreement - TipRanks

Oct 07, 2025
pulisher
Oct 07, 2025

Adicet Bio Reports Promising Phase 1 Study Results - TipRanks

Oct 07, 2025
pulisher
Oct 07, 2025

Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) - NewsBreak: Local News & Alerts

Oct 07, 2025
pulisher
Oct 07, 2025

Adicet Bio, Inc. Announces $80 Million Registered Direct Offering - The Joplin Globe

Oct 07, 2025
pulisher
Oct 07, 2025

70.0M shares: Adicet Bio Prices $80M Registered Direct Offering - Stock Titan

Oct 07, 2025
pulisher
Oct 06, 2025

Adicet Bio, Inc. (NASDAQ:ACET) Receives $5.33 Consensus Target Price from Brokerages - Defense World

Oct 06, 2025
pulisher
Oct 05, 2025

What analysts say about Adicet Bio Inc stockMid Cap Growth Trends & Free Explosive Portfolio Gains - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

Evaluating Adicet Bio Inc. with trendline analysisWeekly Trade Recap & Daily Profit Maximizing Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Why Adicet Bio Inc. stock remains on buy listsMarket Activity Report & Reliable Volume Spike Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can Adicet Bio Inc. (1IJA) stock reach $200 price targetQuarterly Portfolio Report & Expert Approved Momentum Ideas - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What to expect from Adicet Bio Inc. in the next 30 days2025 Historical Comparison & AI Forecasted Entry/Exit Points - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Adicet Bio, Inc. (NASDAQ:ACET) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Is Adicet Bio Inc a good long term investmentPrice Action Trading & High Profit Trading Alerts - earlytimes.in

Oct 03, 2025
pulisher
Oct 03, 2025

What momentum shifts mean for Adicet Bio Inc.July 2025 Movers & Community Verified Swing Trade Signals - newser.com

Oct 03, 2025

Adicet Bio Inc Stock (ACET) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):